Ronald Harold Wilfred Cooper, Director of C4 Therapeutics CCCC, has filed 1 purchase and 2 sales on the open market. The latest trade was on 06/24.

RC

RC

Ronald Harold Wilfred Cooper

Director

Company

C4 Therapeutics CCCC

First filing

23/01/09

Trades

32 trades

Buys / sales

1 / 2

12-month net buying

No record

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
enGene TherapeuticsENGN	Open-market buy	24/09/27	24/10/01	10,000 sh	$5.70	$57,000	No record
AP Albireo Pharma	Open-market sale	23/01/23	23/01/23	1,057 sh	$43.80	$46,296.6	−1.8%
AP Albireo Pharma	Open-market saleAmendment	22/10/24	23/01/09	919 sh	$19.58	$17,994.02	−1.5%